Colorectal liver metastases

British Medical Bulletin

Volumn 99, Issue 1, 2011, Pages 107-124

  Sutcliffe, Robert P ^a   Bhattacharya, Satyajit ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Colorectal liver metastases; Surgery

Indexed keywords

BEVACIZUMAB; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; FOLLOW UP; HEALTH CARE PLANNING; HUMAN; LIVER METASTASIS; LIVER RESECTION; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SURVIVAL RATE; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CATHETER ABLATION; CLINICAL PROTOCOLS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HEALTH STATUS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PATIENT CARE PLANNING; PREOPERATIVE CARE; RESEARCH DESIGN;

EID: 80052705091     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldr034     Document Type: Article

References (86)

1. Stangl R, Altendorf-Hofmann A, Charnley RM et al. Factors influencing the natural history of colorectal liver metastases. Lancet 1994;343:1405-10. (Pubitemid 24167517)
2. Wagner JS, Adson MA, Van Heerden JA et al. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 1984;199:502-8. (Pubitemid 14105105)
3. Morris EJ, Forman D, Thomas JD et al. Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 2010;97:1110-8.
4. Vibert E, Canedo L, Adam R. Strategies to treat primary unresectable colorectal liver metastases. Semin Oncol 2005;32(6 Suppl. 8):33-9.
5. Garden OJ, Rees M, Poston GJ et al. Guidelines for resection of colorectal cancer liver metastases. Gut 2006;55(Suppl. 3):iii1-8. (Pubitemid 44085662)
6. Southampton University Hospitals NHS Trust. Follow-up study of patients who have undergone surgery for stage I, stage II, or stage III colorectal cancer. ClinicalTrials.gov [Internet]. Bethesda(MD): National Library of Medicine (US), 2000. http://clinicaltrials.gov/ct2/show/NCT00560365 (9 February 2011, date last accessed).
7. Mann GN, Marx HF, Lai LL et al. Clinical and cost effectiveness of a new hepatocellular MRI contrast agent, mangafodipir trisodium, in the preoperative assessment of liver resectability. Ann Surg Oncol 2001;8:573-9. (Pubitemid 32735037)
8. Kulemann V, Schima W, Tamandl D et al. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?. Eur J Radiol 2010, April 12 (Epub ahead of print).
9. Sahani DV, Kalva SP, Fischman AJ et al. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. AJR. Am J Roentgenol 2005;185:239-46.
10. Muhi A, Ichikawa T, Motosugi U et al. Diagnosis of colorectal hepatic metastases: contrast-enhanced ultrasonography versus contrast-enhanced computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging with diffusion-weighted imaging. J Magn Reson Imaging 2010;32:1132-40.
11. Fernandez FG, Drebin JA, Linehan DC et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004;240:438-47.
12. Truant S, Huglo D, Hebbar M et al. Prospective evaluation of the impact of [18F] fluro-2-deoxy-D-glucose positron emission tomography of respectable colorectal liver metastases. Br J Surg 2005;92:362-9. (Pubitemid 40445601)
13. Rees M, Tekkis PP, Welsh FK et al. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008;247:125-35.
14. Breitenstein S, DeOliveira ML, Raptis DA et al. Novel and simple preoperative score predicting complications after liver resection in noncirrhotic patients. Ann Surg 2010;252:726-34.
15. Simons JP, Hill JS, Ng SC et al. Perioperative mortality for management of hepatic neoplasm: a simple risk score. Ann Surg 2009;250:929-34.
16. van Ooijen B, Wiggers T, Meijer S et al. Hepatic resections for colorectal metastases in The Netherlands. A multiinstitutional 10-year study. Cancer 1992;70:28-34.
17. Fortner JG, Silva JS, Golbey RB et al. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 1984;199:306-16. (Pubitemid 14194076)
18. Charnsangavej C, Clary B, Fong Y et al. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006;13:1261-8. (Pubitemid 44435791)
19. Altendorf-Hofmann A, Scheele J. A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am 2003;12:165-92. (Pubitemid 36210866)
20. Pawlik TM, Scoggins CR, Zorzi D et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005;241:715-22.
21. Shoup M, Gonen M, D'Angelica M et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 2003;7:325-30. (Pubitemid 36875770)
22. Pulitanò C, Bodingbauer M, Aldrighetti L et al. Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. Ann Surg Oncol 2011;18:1380-8.
23. Elias DM, Ouellet JF. Incidence, distribution, and significance of hilar lymph node metastases in hepatic colorectal metastases. Surg Oncol Clin N Am 2003;12:221-9. (Pubitemid 36204989)
24. Jaeck D, Nakano H, Bachellier P et al. Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Ann Surg Oncol 2002;9:430-8. (Pubitemid 34625801)
25. Adam R, de Haas RJ, Wicherts DA et al. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?. J Clin Oncol 2008;26:3672-80.
26. Elias D, Saric J, Jaeck D et al. Prospective study of microscopic lymph node involvement of the hepatic pedicle during curative hepatectomy for colorectal metastases. Br J Surg 1996;83:942-5. (Pubitemid 26228209)
27. Laurent C, Sa Cunha A, Rullier E et al. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis. J Am Coll Surg 2004;198:884-91. (Pubitemid 38759838)
28. Miller G, Biernacki P, Kemeny NE et al. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg 2007;205:231-8. (Pubitemid 47095434)
29. Mineo TC, Ambrogi V, Tonini G et al. Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma. J Am Coll Surg 2003;197:386-91. (Pubitemid 38373297)
30. Reddy RH, Kumar B, Shah R et al. Staged pulmonary and hepatic metastasectomy in colorectal cancer-is it worth it?. Eur J Cardiothorac Surg 2004;25:151-4. (Pubitemid 38125072)
31. Shah SA, Haddad R, Al-Sukhni W et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 2006;202:468-75. (Pubitemid 43356222)
32. Aoki T, Umekita N, Tanaka S et al. Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin. Surgery 2008;143:706-14.
33. de Haas RJ, Adam R, Wicherts DA et al. Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg 2010;97:1279-89.
34. Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 2000;231:743-51. (Pubitemid 30249836)
35. Verhoef C, van der Pool AE, Nuyttens JJ et al. The liver-first approach for patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum 2009;52:23-30.
36. Mentha G, Roth AD, Terraz S et al. Liver first approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg 2008;25:430-5.
37. van der Pool AE, de Wilt JH, Lalmahomed ZS et al. Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases. Br J Surg 2010;97:383-90.
38. Pamecha V, Glantzounis G, Davies N et al. Long term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases. Ann Surg Oncol 2009;16:1202-7.
39. Tanaka K, Shimada H, Matsuo K et al. Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases. Eur J Surg Oncol 2007;33:329-35. (Pubitemid 46488669)
40. Zorzi D, Chun YS, Madoff DC et al. Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann Surg Oncol 2008;15:2765-72.
41. Tanaka K, Kumamoto T, Matsuyama R et al. Influence of chemotherapy on liver regeneration induced by portal vein embolization or first hepatectomy of a staged procedure for colorectal liver metastases. J Gastrointest Surg 2010;14:359-68.
42. Gold JS, Are C, Kornprat P et al. Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Ann Surg 2008;247:109-17.
43. Stewart GD, O'Súilleabháin CB, Madhavan KK et al. The extent of resection influences outcome following hepatectomy for colorectal liver metastases. Eur J Surg Oncol 2004;30:370-6. (Pubitemid 38528920)
44. Lalmahomed ZS, Ayez N, van der Pool AE et al. Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome?. World J Surg 2011;35:656-61.
45. Zorzi D, Mullen JT, Abdalla EK et al. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 2006;10:86-94. (Pubitemid 41820593)
46. Nguyen KT, Geller DA. Outcomes of laparoscopic hepatic resection for colorectal cancer metastases. J Surg Oncol 2010;102:975-7.
47. Tranchart H, Diop PS, Lainas P et al. Laparoscopic major hepatectomy can be safely performed with colorectal surgery for synchronous colorectal liver metastasis. HPB (Oxford) 2011;13:46-50.
48. Mirnezami R, Mirnezami A, Chandrakumaran K et al. Short and long term outcomes after laparoscopic and open hepatic resection: systematic review and meta-analysis. HPB(Oxford) 2011;13:295-308.
49. Karoui M, Vigano L, Goyer P et al. Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases. Br J Surg 2010;97:1354-62.
50. Tsai S, Marques HP, de Jong MC et al. Two-stage strategy for patients with extensive bilateral colorectal liver metastases. HPB (Oxford) 2010;12:262-9.
51. Alberts SR, Wagman LD. Chemotherapy for colorectal cancer liver metastases. Oncologist 2008;13:1063-73.
52. Kemeny N. Management of liver metastases from colorectal cancer. Oncology (Williston Park) 2006;20:1161-76.
53. Van Cutsem E, Köhne CH, Hitre E et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009;360:1408-17.
54. Liévre A, Bachet JB, Boige V et al. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J Clin Oncol 2008;26:374-9. (Pubitemid 351171687)
55. Bokemeyer C, Bondarenko I, Makhson A et al. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. J Clin Oncol 2009;27:663-71.
56. Hurwitz H, Fehrenbacher L, Novotny W et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-42. (Pubitemid 38702844)
57. Saltz LB, Clarke S, Díaz-Rubio E et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 2008;26:2013-9.
58. Ellis LM, Curley SA, Grothey A. Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. J Clin Oncol 2005;23:4853-5. (Pubitemid 46223989)
59. Mahfud M, Breitenstein S, El-Badry AM et al. Impact of preoperative bevacizumab on complications after resection of colorectal liver metastases: case-matched control study. World J Surg 2010;34:92-100.
60. Tamandl D, Gruenberger B, Klinger M et al. Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study. Ann Surg 2010;252:124-30.
61. Adam R, Delvart V, Pascal G et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004;240:644-57.
62. Perez-Staub N, Lledo G, Paye F et al. Surgery of colorectal metastasis in the Optimox 1 study. A GERCOR study. J Clin Oncol 2006;24(18 Suppl.):3522.
63. Nordlinger B, Sorbye H, Glimelius B et al. EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD). Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008;371:1007-16. (Pubitemid 351392040)
64. Karoui M, Penna C, Amin-Hashem M et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006;243:1-7. (Pubitemid 43054046)
65. Vauthey JN, Pawlik TM, Ribero D et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065-72. (Pubitemid 46622116)
66. Benoist S, Brouquet A, Penna C et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure?. J Clin Oncol 2006;24:3939-45. (Pubitemid 46630742)
67. Portier G, Elias D, Bouche O et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 2006;24:4976-82. (Pubitemid 46631399)
68. Adam R, Akpinar E, Johann M et al. Place of cryosurgery in the treatment of malignant liver tumours. Ann Surg 1997;225:39-48.
69. Boutros C, Somasundar P, Garrean S et al. Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis. Surg Oncol 2010;19:e22-32.
70. Garrean S, Hering J, Saied A et al. Ultrasound monitoring of a novel microwave ablation (MWA) device in porcine liver: lessons learned and phenomena observed on ablative effects near major intrahepatic vessels. J Gastrointest Surg 2009;13:334-40.
71. Poon RT, Ng KK, Lam CM et al. Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg 2004;239:441-9. (Pubitemid 38372759)
72. Jaskolka JD, Asch MR, Kachura JR et al. Needle tract seeding after radiofrequency ablation of hepatic tumors. J Vasc Interv Radiol 2005;16:485-91. (Pubitemid 40464191)
73. Hildebrand P, Leibecke T, Kleemann M et al. Influence of operator experience in radiofrequency ablation of malignant liver tumours on treatment outcome. Eur J Surg Oncol 2006;32:430-4. (Pubitemid 44287671)
74. Mulier S, Ni Y, Jamart J et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005;242:158-71. (Pubitemid 41033431)
75. Abdalla EK, Vauthey JN, Ellis LM et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818-25.
76. Iannitti DA, Dupuy DE, Mayo-Smith WW et al. Hepatic radiofrequency ablation. Arch Surg 2002;137:422-6.
77. Oshowo A, Gillams A, Harrison E et al. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 2003;90:1240-3. (Pubitemid 37330428)
78. Welsh JS, Kennedy AS, Thomadsen B. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2006;66(2 Suppl.):S62-73. (Pubitemid 44353951)
79. Gulec SA, Fong Y. Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases. Arch Surg 2007;142:675-82. (Pubitemid 47080453)
80. Van Hazel G, Blackwell A, Anderson J et al. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 2004;88:78-85. (Pubitemid 39536508)
81. Mann CD, Metcalfe MS, Neal CP et al. Role of ultrasonography in the detection of resectable recurrence after hepatectomy for colorectal liver metastases. Br J Surg 2007;94:1403-7. (Pubitemid 350144390)
82. Bhattacharjya S, Aggarwal R, Davidson BR. Intensive follow-up after liver resection for colorectal liver metastases: results of combined serial tumour marker estimations and computed tomography of the chest and abdomen-a prospective study. Br J Cancer 2006;95:21-6. (Pubitemid 43980549)
83. Malik HZ, Gomez D, Wong V et al. Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. Eur J Surg Oncol 2007;33:1003-9. (Pubitemid 47408735)
84. Thelen A, Jonas S, Benckert C et al. Repeat liver resection for recurrent liver metastases from colorectal cancer. Eur J Surg Oncol 2007;33:324-8. (Pubitemid 46499229)
85. Yan TD, Lian KQ, Chang D et al. Management of intrahepatic recurrence after curative treatment of colorectal liver metastases. Br J Surg 2006;93:854-9. (Pubitemid 44035258)
86. Petrowsky H, Gonen M, Jarnagin W et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 2002;235:863-71. (Pubitemid 34547306)